| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Academic Unit of Child Health (P.B., C.P.S.), University of Manchester, St. Marys Hospital, Manchester M13 0JH, United Kingdom; and School of Animal and Microbial Sciences (N.J.B., R.J.W., P.J.L., N.M.P.), University of Reading, Reading RG6 6AJ, United Kingdom
Address all correspondence and requests for reprints to: Paul Brownbill, Academic Unit of Child Health, University of Manchester, St. Marys Hospital, Hathersage Road, Manchester M13 0JH, United Kingdom. E-mail: paul.brownbill{at}man.ac.uk.
Neurokinin (NK) B is a member of the tachykinin family of neurotransmitters, exerting hypotensive or hypertensive effects in the mammalian vasculature through synaptic release from peripheral neurons, according to either NK1 and NK2 or NK3 receptor subtype expression, respectively. There is recent evidence that NKB is expressed by the syncytiotrophoblast of the human placenta, an organ that is not innervated. We hypothesized that NKB is a paracrine modulator of tone in the fetal placental circulation. We tested this hypothesis using the in vitro perfused human placental cotyledon. Our data show that NKB is a dilator of the fetal vasculature, causing a maximal 25.1 ± 4.5% (mean ± SEM; n = 5) decrease in fetal-side arterial hydrostatic pressure (5-µM NKB bolus; effective concentration in the circulation, 1.89 nM) after preconstriction with U-46619. RT-PCR demonstrated the presence of mRNA for NK1 and NK2 tachykinin receptors in the placenta. Using selective receptor antagonists, we found that NKB-induced vasodilation is through the NK1 receptor subtype. We found no evidence for the involvement of either nitric oxide or prostacyclin in this response. This study demonstrates a paracrine role for NKB in the regulation of fetal placental vascular tone.
This work was supported by an Action Research Endowment Fund (Manchester group funding) and an Medical Research Council program grant (Reading group funding). N.J.B. holds a Society for Endocrinology Prize studentship.
Abbreviations: FAHP, Fetal arterial hydrostatic pressure; FMAHP, fetal and MAHP; HUVEC, human umbilical vein endothelial cell; L-NAME, nitro-L-arginine methyl ester hydrochloride; MAHP, maternal arterial hydrostatic pressure; NK, neurokinin; NO, nitric oxide.
This article has been cited by other articles:
![]() |
P. Brownbill, G. C. McKeeman, J. C. Brockelsby, I. P. Crocker, and C. P. Sibley Vasoactive and Permeability Effects of Vascular Endothelial Growth Factor-165 in the Term in Vitro Dually Perfused Human Placental Lobule Endocrinology, October 1, 2007; 148(10): 4734 - 4744. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Cleal, P. Brownbill, K. M. Godfrey, J. M. Jackson, A. A. Jackson, C. P. Sibley, M. A. Hanson, and R. M. Lewis Modification of fetal plasma amino acid composition by placental amino acid exchangers in vitro J. Physiol., July 15, 2007; 582(2): 871 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pal, J. Wu, J. K. Murray, S. H. Gellman, M. A. Wozniak, P. J. Keely, M. E. Boyer, T. M. Gomez, S. M. Hasso, J. F. Fallon, et al. An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis J. Cell Biol., September 25, 2006; 174(7): 1047 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.M. Page, J. Dakour, and D.W. Morrish Gene regulation of neurokinin B and its receptor NK3 in late pregnancy and pre-eclampsia Mol. Hum. Reprod., July 1, 2006; 12(7): 427 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Marzioni, G. Fiore, A. Giordano, M. Nabissi, P. Florio, F. Verdenelli, F. Petraglia, and M. Castellucci Placental Expression of Substance P and Vasoactive Intestinal Peptide: Evidence for a Local Effect on Hormone Release J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2378 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pal, M. J. Nemeth, D. Bodine, J. L. Miller, J. Svaren, S. L. Thein, P. J. Lowry, and E. H. Bresnick Neurokinin-B Transcription in Erythroid Cells: DIRECT ACTIVATION BY THE HEMATOPOIETIC TRANSCRIPTION FACTOR GATA-1 J. Biol. Chem., July 23, 2004; 279(30): 31348 - 31356. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, J. Dakour, S. Kaufman, L. J. Guilbert, B. Winkler-Lowen, and D. W. Morrish Adrenomedullin Is Decreased in Preeclampsia Because of Failed Response to Epidermal Growth Factor and Impaired Syncytialization Hypertension, November 1, 2003; 42(5): 895 - 900. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |